TrialBlood advances2025

Impact of concomitant azoles on ruxolitinib treatment in patients with GVHD: post hoc analyses of REACH2 and REACH3.

Zahra Mahmoudjafari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.